
TH-263
CAS No. 313520-94-4
TH-263( —— )
Catalog No. M22572 CAS No. 313520-94-4
TH-263 is inactive toward both LIMK1 and LIMK2 and thus can be used as negative control for TH-257, and is a diaryl sulfonamide derivative.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 146 | In Stock |
![]() ![]() |
10MG | 228 | In Stock |
![]() ![]() |
25MG | 444 | In Stock |
![]() ![]() |
50MG | 620 | In Stock |
![]() ![]() |
100MG | 878 | In Stock |
![]() ![]() |
500MG | 1755 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameTH-263
-
NoteResearch use only, not for human use.
-
Brief DescriptionTH-263 is inactive toward both LIMK1 and LIMK2 and thus can be used as negative control for TH-257, and is a diaryl sulfonamide derivative.
-
DescriptionTH-263 is inactive toward both LIMK1 and LIMK2 and thus can be used as negative control for TH-257, and is a diaryl sulfonamide derivative.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number313520-94-4
-
Formula Weight380.46
-
Molecular FormulaC21H20N2O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NCc1ccccc1)c1ccc(cc1)S(=O)(=O)NCc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Manetti F. Recent advances in the rational design and development of LIM kinase inhibitors are not enough to enter clinical trials. Eur J Med Chem. 2018 Jul 15;155:445-458.
molnova catalog



related products
-
Thalidomide-O-amido-...
Thalidomide-O-amido-C6-NH2 TFA, a synthesized E3 ligase ligand-linker conjugate containing a Thalidomide-based cereblon ligand and a linker.
-
Isonicotinamide
Pharmaceutical intermediate used to synthesis Cefalonium, etc.
-
3-(Methylamino)tolue...
Used as dye intermediates.